ClinicalTrials.Veeva

Menu

Optokinetic Stimulation for Hemineglect

U

University of Salamanca

Status

Enrolling

Conditions

Perceptual Disorders
Unilateral Spatial Neglect

Treatments

Other: Placebo
Other: Optokinetic stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT04663646
NEUROUSAL02/2020

Details and patient eligibility

About

Hemineglect is a sequel to stroke, which appears more frequently when the injury occurs in the right cerebral hemisphere. Hemineglect refers to those patients who do not pay attention to their left side, presenting movement disorders that do not allow them to participate spontaneously in their activities of daily life.

There are different methodologies for the treatment of hemineglect. Among them, we find optokinetic stimulation (OKS), which consists of creating an illusory movement to the left to center the patient's frame of reference and thus, make them pay more attention to their left side. In recent years, the effect that this therapy has on motor movement disorders has begun to be explored, although the parameters for its correct application still seem to be unclear.

For this reason, our aim is to describe the effect that the OKS has on balance, posture, spatial representation and conscience, and movement disorders in hemineglect. Patients with hemineglect will undergo OKS to see its influence on the recovery of this sequel of stroke.

Enrollment

102 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 year old or older
  • Diagnosis of right stroke
  • Diagnosis of left heminegligence

Exclusion criteria

  • No cooperation and comunication problems
  • Uncontrolled epileptic seizures or migraines

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

102 participants in 2 patient groups, including a placebo group

Intervention Group
Experimental group
Treatment:
Other: Optokinetic stimulation
Control Group
Placebo Comparator group
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Central trial contact

Fátima Pérez-Robledo, Doctor; Rocío Llamas-Ramos, Doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems